Risk of having BRCA mutations in women with triple-negative breast cancer: A systematic review and meta-analysis

被引：1
|
作者：
Tun, N. M. [1 ]
Villani, G. M. [1 ]
Ong, K. [1 ]
机构：
[1] Brooklyn Hosp Ctr, Brooklyn, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 27期
关键词：
D O I：
10.1200/jco.2011.29.27_suppl.160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
160
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The prevalence of BRCA1 mutations among young women with triple-negative breast cancer
    Young, S. R.
    Pilarski, Robert T.
    Donenberg, Talia
    Shapiro, Charles
    Hammond, Lyn S.
    Miller, Judith
    Brooks, Karen A.
    Cohen, Stephanie
    Tenenholz, Beverly
    DeSai, Damini
    Zandvakili, Inuk
    Royer, Robert
    Li, Song
    Narod, Steven A.
    [J]. BMC CANCER, 2009, 9
  • [32] BRCA Mutations and Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Chandan, Saurabh
    Deliwala, Smit S.
    Facciorusso, Antonio
    Mohan, Babu
    Kochhar, Gursimran S.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S40 - S41
  • [33] Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis
    Baretta, Zora
    Mocellin, Simone
    Goldin, Elena
    Olopade, Olufunmilayo I.
    Huo, Dezheng
    [J]. MEDICINE, 2016, 95 (40)
  • [34] Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysis
    Shi, Mingqiang
    Li, Zhoujuan
    Wang, Tianzhuo
    Wang, Miaozhou
    Liu, Zhen
    Zhao, Fuxing
    Ren, Dengfeng
    Zhao, Jiuda
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2024, 47 (02): : 91 - 98
  • [35] Androgen Receptor, EGFR, and BRCA1 as Biomarkers in Triple-Negative Breast Cancer: A Meta-Analysis
    Zhang, Li
    Fang, Cheng
    Xu, Xianqun
    Li, Anling
    Cai, Qing
    Long, Xinghua
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [36] Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
    Liu, Xu
    Wu, Kan
    Zheng, Dan
    Luo, Chuanxu
    Fan, Yu
    Zhong, Xiaorong
    Zheng, Hong
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Immune checkpoint inhibitors as neoadjuvant therapy in early triple-negative breast cancer: A systematic review and meta-analysis
    Mittal, Niti
    Singh, Surjit
    Mittal, Rakesh
    Kaushal, Jyoti
    Kaushal, Vivek
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1754 - +
  • [38] Platinum-based chemotherapy for early triple-negative breast cancer: A Cochrane systematic review and meta-analysis
    Mason, Sofia
    Willson, Melina
    Goodwin, Annabel
    Beith, Jane
    Egger, Sam J.
    Dear, Rachel F.
    [J]. CANCER RESEARCH, 2023, 83 (05)
  • [39] The unique risk factor profile of triple-negative breast cancer: a comprehensive meta-analysis
    Kumar, Nitya
    Ehsan, Sarah
    Banerjee, Shahana
    Perez, Claudia Fernandez
    Lhuilier, Isabelle
    Neuner, Jillian
    Friebel-Klingner, Tara
    Fayanju, Oluwadamilola M.
    Nair, Bindhu
    Niinuma, Sara Anjum
    Nampoothiri, Shivangi
    McCarthy, Anne Marie
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (08): : 1210 - 1219
  • [40] A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancer
    Jia, Xiaomeng
    Wang, Kainan
    Xu, Lingzhi
    Li, Ning
    Zhao, Zuowei
    Li, Man
    [J]. BREAST, 2022, 66 : 31 - 39
12345